Analysis of the ability of different health status and dyspnea measures to predict 5-year mortality in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 251s Year: 2002
COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Characterization of exercise impairment in relation to quality of life (QoL) and hospital admission in COPD patients; data from the INTERCOM trial Source: Eur Respir J 2005; 26: Suppl. 49, 433s Year: 2005
Effect of age, gender, severity and smoking status on rate of decline of FEV1 in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 517s Year: 2005
Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Health status measurement in COPD patients. Correlations with dyspnea and physiologic outcomes Source: Eur Respir J 2005; 26: Suppl. 49, 515s Year: 2005
Should we use gait speed in COPD, FEV1 in frailty and dyspnoea in both? Source: Eur Respir J 2016; 48: 315-319 Year: 2016
Association between patient-reported outcomes and exercise test outcomes in patients with COPD. Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases Year: 2020
Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
Revefenacin (REV) improves health status and dyspnea regardless of baseline symptom status in chronic obstructive pulmonary disease (COPD): a post hoc analysis of phase 3 trials Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Limited clinical relevance of the 6MWD in relation to complaints and quality of life in COPD Source: Annual Congress 2009 - Exploring outcome measures in COPD and pulmonary rehabilitation Year: 2009
COPD characteristics and progression of patients with high vs low health status: an analysis of the observational DACCORD study Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019
Dealing with missing longitudinal FEV1 observations when used as time-dependent covariate data in survival analysis for COPD patients within a regional UK population-level database Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Differences in health related quality of life among caregivers of COPD patients according to the level of perceived burden Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020
Relationship between quality of life and clinical status in asthma: a factor analysis Source: Eur Respir J 2004; 23: 287-291 Year: 2004
Repeated hospitalizations in patients and chronic respiratory failure due to COPD are best predicted by health status (QoL) and effort tolerance Source: Eur Respir J 2003; 22: Suppl. 45, 575s Year: 2003
Mortality risks related to smoking and low FEV1 differ in subgroups according to age and gender in a long-term follow-up - the Malmö prevention project Source: Eur Respir J 2001; 18: Suppl. 33, 273s Year: 2001
Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017